Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, its Investor Class fund ARTMX returned -1.13%, Advisor Class fund APDMX posted a return of -1.12%, and Institutional Class fund APHMX returned -1.07%, compared to a return of 6.90% for the Russell Midcap Growth Index. In addition, please check the fund’s top five holdings to know its best picks in 2022.
Artisan Partners highlighted stocks like DexCom, Inc. (NASDAQ:DXCM) in the Q4 2022 investor letter. Headquartered in San Diego, California, DexCom, Inc. (NASDAQ:DXCM) is a medical device company. On January 19, 2023, DexCom, Inc. (NASDAQ:DXCM) stock closed at $106.20 per share. One-month return of DexCom, Inc. (NASDAQ:DXCM) was -4.70%, and its shares gained 0.64% of their value over the last 52 weeks. DexCom, Inc. (NASDAQ:DXCM) has a market capitalization of $41.021 billion.
Artisan Partners made the following comment about DexCom, Inc. (NASDAQ:DXCM) in its Q4 2022 investor letter:
“DexCom, Inc. (NASDAQ:DXCM) is the leader in continuous glucose-monitoring (CGM) systems. We believe it is well-positioned to continue penetrating the Type 1 diabetes market and drive adoption in the much larger Type 2 diabetes market, where data supporting the clinical and economic case for CGM sensors is building. The company experienced several pieces of good news this quarter. Third quarter sales and profits accelerated, Medicare announced it will reimburse CGM devices for non-insulin intensive Type 2 diabetes patients in 2023, and, importantly, the company received FDA approval for its next-gen G7 sensor. The launch of its G7 product—60% smaller than G6, fully disposable, interoperable with a variety of insulin delivery technologies—should enable the company to gain further share of non-insulin dependent Type 2 diabetes and gestational diabetes patients.”
DexCom, Inc. (NASDAQ:DXCM) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 62 hedge fund portfolios held DexCom, Inc. (NASDAQ:DXCM) at the end of the third quarter which was 56 in the previous quarter.
We discussed DexCom, Inc. (NASDAQ:DXCM) in another article and shared the best medical technology stocks to buy. In addition, please check out our hedge fund investor letters Q4 2022 page for more investor letters from hedge funds and other leading investors.
Suggested Articles:
12 Best DRIP Stocks To Own
25 Biggest Colorado Companies
25 Biggest Florida Companies
Disclosure: None. This article is originally published at Insider Monkey.
Related Quotes
Does the January share price for Neonode Inc. ( NASDAQ:NEON ) reflect what it's really worth? Today, we will estimate…
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, its Investor Class fund ARTMX returned -1.13%, Advisor Class fund APDMX posted a return of -1.12%, and Institutional Class fund APHMX returned -1.07%, compared to a […]
A discussion of "growth stocks" may not thrill investors quite the way it did just a year or two ago, but this type of investment is quite the horror show some make it out to be. Here are two no-brainer growth stocks still worthy of the designation to consider adding to your portfolio before the end of January. DexCom (NASDAQ: DXCM) has a relatively small portfolio of products, with its flagship product being its G series of continuous glucose monitoring (CGM) devices.
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd…
A proactive approach that prioritizes the wellbeing and development of employees has secured a Canadian Top Employer spot for Imperial Tobacco Canada.
Equinor (EQNR) closed at $30.81 in the latest trading session, marking a -1.09% move from the prior day.
Gov. Laura Kelly, a Democrat, has asked for $500 million in tax cuts over three years.
Wayfair Inc (NYSE: W) revealed a reduction of approximately 1,750 employees, representing 10% of its global workforce as of Dec. 31, 2022. This includes approximately 1,200 or 18% of corporate employees. Inclusive of the August 2022 restructuring, the labor portion of the plan represents approximately $750 million in annualized cost savings, with the steps essential to realize these savings now complete. "In hindsight, similar to our technology peers, we scaled our spend too quickly over the las
Investors can play a role in ensuring a more sustainable water future by allocating capital to companies that provide water solutions.
The Chiefs finished the regular season with a 14-3 record, and their 10-member rookie class did more than its share to contribute.
In this article, we discuss 12 hot penny stocks on the rise. If you want to see more stocks in this selection, check out 5 Hot Penny Stocks On the Rise. Penny stocks usually trade under $5 and are favored by new investors or market participants who prefer day trading. Some key indicators that penny […]
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
Cathie Wood's ARK Innovation ETF is back — and back big. It's the top diversified ETF again this year so far, largely due to big winners.
Shares of Scilex Holding (NASDAQ: SCLX) were up 39.7% this week as of Thursday, according to data provided by S&P Global Market Intelligence. Scilex develops non-opioid treatments for acute and chronic pain. The healthcare company is majority owned by Sorrento Therapeutics, and there have been rumors of a potential buyout.
Her Ark funds have snagged 806,663 Tesla shares in January alone, recently valued at $105.4 million.
Slightly more dovish comments from Fed officials and positive commentary on Southeast Asia at Davos helped light a fire under Sea's stock today.
The latest update from an industry darling could signal big financial challenges for marijuana companies.
Although oil prices are prone to fluctuate, the rising earnings estimate revisions for these stocks are a great sign with several of these equities offering solid dividends to support patient investors.
Nio (NYSE: NIO) shares jumped more than 5% Friday morning and were holding on to a gain of 3% as of 2:33 p.m. ET. Nio — like other Chinese automakers — has been hit by multiple rounds of business slowdowns due to COVID-19-related shutdowns and drops in consumer demand over the past year. The slump in EV demand has led to vehicle price drops by EV leader Tesla in China that were followed by cuts from other domestic EV makers.
Investors have turned their attention to profits and cash flow as interest rates have risen. Does that give the edge to PayPal (NASDAQ: PYPL) stock or to SoFi (NASDAQ: SOFI) stock? This video will answer that question, so tune in to find out.
